Seeking Alpha

Exelixis Inc. (EXEL)

()

News & PR
Market Currents

Buzz
Twitter: EXEL

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

ImmunoCellular's Promising Brain Cancer Vaccine

Oct 28 • Mike Havrilla • 2 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Sep 20 • Justin M. Hall • 3 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Sep 11 • Justin M. Hall • 23 Comments
Small Cap Stocks Battling Brain Cancer

Sep 7 • Mike Havrilla • 4 Comments
Three Recent Biotech Activist Wins by Carl Icahn

Aug 31 • Michael Becker • 4 Comments
Wall Street Breakfast: Must-Know News

Jul 31 • SA Editor Rachael Granby • 14 Comments
Breakout Stocks on Huge Volume: Three Option Trades

Jul 27 • Marco Hickey • 4 Comments
15 Overvalued Small Caps from Russell 2000

Jul 8 • Value Expectations • 5 Comments
Keryx: Another Beneficiary of the ASCO Effect

Jun 3 • Michael Becker • 5 Comments
Two Potential Mega Biotech Deals Fuel Industry Hopes

May 31 • The Burrill Report • 2 Comments
Friday Options Recap

May 29 • Frederic Ruffy • 2 Comments
Thursday Options Update: SVNT, WFC, EEM, MCO, XHB, EXEL, GDX, HIG

May 28 • Andrew Wilkinson • Comment!
Top Biotech Picks for ASCO 2009 (Part II)

May 27 • Ohad Hammer • 2 Comments
Top Biotech Picks for ASCO 2009 (Part I)

May 27 • Ohad Hammer • 2 Comments
Exelixis Suggests Creativity in Finding Cash for Biotechs in Rough Times

May 26 • The Burrill Report • Comment!
Micromet: More Reasons for Optimism

May 11 • Ohad Hammer • 7 Comments
9 Possible Pharma Deals for 2009

Jan 8 • Zacks.com • 7 Comments
40 Top Rated Emerging Bio-Pharma Stocks

Dec 23, 2008 • Mike Havrilla • Comment!
Immunogen and Exelixis Defy the Recession

Dec 22, 2008 • Ohad Hammer • Comment!
Bristol-Myers' Collaboration with Exelixis Is Looking Lucrative

Nov 24, 2008 • Eben Tessari • Comment!
Buying More Exelixis in the Post - GlaxoSmithKline Era

Oct 28, 2008 • Ohad Hammer • Comment!
'When There's Blood in the Streets', Buy Biotech Stocks

Oct 10, 2008 • Ohad Hammer • 13 Comments
Licensing Deal Is Imminent for ArQule

Oct 2, 2008 • Ohad Hammer • 6 Comments
Exelixis: A Platform Company for Oncology

Sep 3, 2008 • Ohad Hammer • 4 Comments
Poniard Pharmaceuticals: Platinum Rediscovered (Part II)

Jun 24, 2008 • Ohad Hammer • 5 Comments
Cancer Stocks: Tracking the Market

Jul 9, 2007 • Alan Brochstein • Comment!
Cancer Stocks: The Bleeding Slows

Jul 2, 2007 • Alan Brochstein • Comment!
Cancer Stocks Hammered Once Again

Jun 26, 2007 • Alan Brochstein • 7 Comments
Cancer Stocks Slide Again

Jun 18, 2007 • Alan Brochstein • 1 Comment
Cancer Stocks Plunge Following ASCO Meeting

Jun 11, 2007 • Alan Brochstein • 3 Comments
Four Cheap Biotech Stock Picks: Amgen, Aspreva, Exelixis, PDL Biopharma

May 17, 2007 • James Cullen • Comment!
Four Conviction Buys for Our Age of Uncertainty

Mar 19, 2007 • Travis Johnson • Comment!
Biotech In Review: Adams Respiratory Guides Lower

Mar 18, 2007 • Centient Biotech Investor • Comment!
Biotech Stocks Day In Review: Alfacell Receives Orphan Drug Status For Onconase

Jan 31, 2007 • Centient Biotech Investor • Comment!
Report From JPMorgan's HealthCare Conference: The Spinal Business Is Hot

Jan 10, 2007 • Centient Biotech Investor • Comment!
Biotech Stocks Day-in-Review: Amgen Strikes Drug Deal With Cytokinetics

Jan 4, 2007 • Centient Biotech Investor • Comment!
Exelixis' Special Purpose Entities A Far Cry From Enron (EXEL)

Apr 11, 2006 • Travis Johnson • Comment!
Exelixis Upgraded With Good Reason (EXEL)

Mar 29, 2006 • Travis Johnson • 3 Comments
Waiting For More Good News From Exelixis (EXEL)

Nov 7, 2005 • Travis Johnson • Comment!
Stocks Covered by The Biotech Stock Blog

Oct 11, 2005 • Comment!
How Exelixis Excels (EXEL)

Sep 25, 2005 • Travis Johnson • Comment!

Exelixis Inc. (EXEL)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers